lifestyle.californiaconsumerbanking.com

Author: Quest Diagnostics Incorporated

City of Hope to Evaluate Quest Diagnostics’ Haystack MRD® for Guiding Patient Management in Multiple Cancers

May 6, 2026
Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors

May 1, 2026
Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results

April 29, 2026
Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer

April 29, 2026
Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference

April 29, 2026
Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

April 21, 2026
Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026

March 19, 2026
Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization

March 9, 2026
Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease

February 2, 2026
Quest Diagnostics Named to Fortune’s World’s Most Admired Companies List for 12th Consecutive Year

January 23, 2026